A new option in airway management: evaluation of the TotalTrack® video laryngeal maski by Choonoo, JO et al.
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/ojfp 20
Southern African Journal of Anaesthesia and Analgesia is co-published by Medpharm Publications, NISC (Pty) Ltd and Cogent, Taylor & Francis Group
Southern African Journal of Anaesthesia and Analgesia  2016; 22(2):52–56
http://dx.doi.org/10.1080/22201181.2016.1159784
Open Access article distributed under the terms of the
Creative Commons License [CC BY-NC-ND 4.0]
http://creativecommons.org/licenses/by-nc-nd/4.0
South Afr J Anaesth Analg
ISSN 2220-1181 EISSN 2220-1173
© 2016 The Author(s)
RESEARCH
A new option in airway management: evaluation of the TotalTrack® video 
laryngeal maski
JO Choonooa , R  Hofmeyra* , NR  Evansb, MF  Jamesa and N  Meyersfeldc
a Faculty of Health Sciences, Department of Anaesthesia, University of Cape Town, Cape Town, South Africa
b ZA Health, Cape Town, South Africa
c Southern Anaesthetics, Cape Town, South Africa
*Corresponding author, email: ross.hofmeyr@uct.ac.za
Background: The TotalTrack® Video Laryngeal Mask (VLM) is a novel airway management device consisting of a disposable 
laryngeal mask paired with a reusable video display. Prior to the commencement of this study, there was no published literature 
on the performance of the TotalTrack®.
Methods: The device was evaluated in sixty patients without predictors for difficult airway under general anaesthesia with 
neuromuscular blockade. Primary outcomes were laryngeal mask seal pressures and success of tracheal intubation through the 
device.
Results: Insertion and ventilation was successful in 98.3% of cases. Median static leak and maximal inflation pressures of the 
laryngeal mask component were 32 and 40 cmH₂O respectively. Tracheal intubation through the device was successful in 95% of 
cases, with a mean intubation time of 9.5 s. No gastric insufflation occurred. Haemodynamic variability was found to be clinically 
insignificant. No significant side-effects were reported.
Conclusions: In this initial study, the TotalTrack® VLM was found to be effective as a laryngeal mask airway, exhibiting good sealing 
pressures. It facilitated predictable, easy intubating conditions under video guidance, with minimal interruption of ventilation.
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Introduction
The TotalTrack® Video Laryngeal Mask (VLM; Medcom Flow, 
Spain) is a new airway management system which is designed to 
combine a second generation supraglottic airway with video 
capabilities, which allows tracheal intubation under vision. It has 
been proposed for use in routine airway management, for 
predicted difficult airways, as a rescue airway device for the 
unanticipated difficult airway, and for video documentation of 
airway management.
The TotalTrack® VLM consists of a disposable laryngeal mask in a 
rigid introducer. The laryngeal mask component has a 
supraglottic suction port, and a conduit for a nasogastric tube. A 
preloaded tracheal tube allows ventilation when functioning as 
a laryngeal mask. A reusable camera and video display 
(Videotrack®) is connected before each use, protected from 
contact with the patient by an isolated channel and clear lens. 
Power is provided to the Videotrack® from a battery pack in the 
disposable portion when the Videotrack® is inserted.1 (Figure 1)
Although the device has been in limited clinical use with 
anecdotal reports of efficacy, there were no prior published case 
series on the use of the device prior to 2015. In order to ascertain 
the basic performance of the device, this study assessed the 
TotalTrack® in a single device descriptive trial, as suggested by 
publications on device testing.2–4 Representation of such data 
regarding a new device, in patients with no obvious airway 
pathology, allows clinicians to assess device efficacy and safety 
in the general population before further studies are conducted 
to ascertain use in difficult airway scenarios. Very recently, a 
series of 100 cases in Spain was published, where further trials in 
anticipated difficult airways are registered.5 Later randomised 
controlled trials with comparison of the device against the gold 
standard in its class may be warranted if the initial trials are 
promising.
Materials and methods
Departmental and institutional ethics approval were granted by 
the University of Cape Town Human Research Ethics Committee. 
Three investigators with more than 5  years’ experience in 
anaesthesia received training in the use of the TotalTrack®.
Figure 1: TotalTrack VLM® and Videotrack (left), and device ready for use 
(right).
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Sixty patients were invited to participate, and written informed 
consent was obtained. This sample size was selected to balance 
risks of assessment of a new device against obtaining sufficient 
measurements for statistical analysis. Patients recruited were 
ASA class I or II, over the age of 18 years, with a lean body mass of 
50 to 80 kg (suitable for a size 4 supraglottic airway). They had no 
indicators of a difficult airway or predictors of delayed gastric 
emptying. The elective procedure had to be of an estimated 
duration of 30 min to 2 h, and necessitate tracheal intubation.
Patients excluded from recruitment were those who were unable 
or unwilling to provide informed consent, those who were 
morbidly obese (BMI  ≥  35  kg.m–²), had overt airway or neck 
pathology, and those with an indication for a rapid sequence 
induction of anaesthesia.
A standardised anaesthetic technique was used. After application 
of routine monitoring, haemodynamic parameters were 
measured and documented at 2.5 min intervals. Midazolam 
1  mg was followed by induction with fentanyl 1  μg.kg–¹ and 
propofol 1.5 - 2.5  mg.kg–¹, titrated until an adequate depth of 
anaesthesia was attained. Rocuronium 0.6  mg.kg–¹ was then 
administered to establish neuromuscular blockade.
After TotalTrack® insertion, adequacy of ventilation was assessed 
by evidence of adequate bilateral chest expansion, expired tidal 
volumes of ≥ 6 ml.kg–¹, adequate oxygenation (SpO2 ≥ 95%), and 
end-tidal carbon dioxide partial pressures of 4 – 6  kPa, with a 
normal capnograph waveform. The time period from first 
handling the device until adequate ventilation was achieved, 
was recorded.
As safety measures within the protocol, insertion and intubation 
processes were limited to two attempts. Failing this, the study 
was abandoned and standard airway management ensued.
After placement of the device, seal pressures were tested using 
manometric stabilisation techniques.6 This involved measuring 
the pressure at which an audible leak was heard at the mouth 
with fresh gas flow at 5 l.min−1, and measuring maximum inflation 
pressure generated when using a slow manual inspiration over 
1.5 to 2 s, with the adjustable pressure-limiting valve closed and 
fresh gas flow at 2 l.min−1. If no leak was generated by 40 cmH₂O, 
testing was deemed adequate and seal pressure was documented 
as 40 cmH₂O. Readings were taken using the anaeroid pressure 
gauge on the circle absorber system. The quality of the laryngeal 
mask seal was assessed in 4 different head positions: flexion, 
extension and 30⁰ rotation from midline to either side, and was 
documented as positive or negative for the presence of a leak.7,8
The presence of gastric insufflation was also assessed by 
auscultation over the epigastrium during manually generated 
pressures of up to 35 cmH₂O.9
Using the Videotrack®, the view of the glottis was graded by 
consensus between the two investigators present at the time, 
using the Cormack-Lehane scale and percentage of glottic 
opening (POGO) score.10,11 (Figure 2)
Once optimal view of the glottis was obtained, the pre-loaded 
tracheal tube (standard Mallinkrodt or Rüsch tracheal tube, 
internal diameter 7.0 to 8.0 mm, as supplied by the hospital) was 
advanced through the glottis. Time for intubation was measured 
from time of optimisation of glottic view on the Videotrack® to 
the time of tracheal tube cuff re-inflation and confirmation of 
adequate ventilation. The need for any assistive device or 
external laryngeal manipulation to aid with tracheal intubation 
was documented. Video recordings of the intubation process 
were made. Only two attempts were allowed, and if these were 
unsuccessful, the device was removed and standard airway 
management ensued. On confirmation of placement, positive 
pressure ventilation was continued throughout the procedure.
A 12 French gauge nasogastric tube was then inserted through 
the specific conduit in the device. Insertion was graded as easy, 
difficult or impossible. Placement was confirmed by aspiration of 
gastric contents and/ or auscultation over the epigastrium whilst 
5  ml of air was insufflated through the nasogastric tube. Once 
testing was complete, the nasogastric tube was removed unless 
the surgical procedure required it to be left in place. At this time, 
the Videotrack® and rigid introducer were removed, the 
TotalTrack® cuff was deflated and the device was left in situ to 
enable post-procedure observations.
Towards the end of surgery, the Videotrack® was re-attached to 
the device and the LMA cuff was re-inflated. If secretions were 
present at the glottis, the supraglottic suction port of the device 
was tested. On return of spontaneous respiration, with the 
patient still anaesthetised, the tracheal tube was withdrawn 
through the LMA before reversal of residual neuromuscular 
blockade. Vocal cord function was assessed and video recordings 
were made.
On completion of surgery, once the patient had adequately 
regained consciousness, the laryngeal mask was removed. Any 
soiling, whether by secretions, gastric contents or blood, was 
documented.
Patients were followed up on the day of-, and the day following 
surgery. Patient-reported side-effects (including sore throat, 
dysphagia and hoarseness) were sought. These were graded as 
mild, moderate or severe. Thereafter, the patients were 
discharged from the study.
Statistica® (Version 12, Statasoft, Tulsa, OK, USA) was used for 
statistical analysis. Means and standard deviations were used to 
describe parametric data; medians and interquartile ranges were 
used to describe non-parametric data; and rates and percentages 
were used for success rates and nominal data. Haemodynamic 
Figure 2: Laryngeal view with totaltrack in situ.
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changes were analysed using repeated measures analysis of 
variance.
Results
Patient characteristics are represented in Tables 1 and 2. Of note, 
only one patient had a thyromental distance of less than 6 cm.
Haemodynamic parameters were documented pre- and post-
insertion of the device as well as pre- and post-intubation, to 
assess for significant changes in mean arterial pressures and 
heart rate with insertion and/or tracheal intubation. Mean 
arterial pressure changes in relation to insertion of the TotalTrack® 
and tracheal intubation varied over a range of 90 to 99 mm Hg, 
while changes in heart rate varied over a range of 83 to 95 beats 
per minute (Figures 3 and 4).
Insertion and ventilation was successful in 59/60 cases (98.3%), 
and mean time to adequate ventilation was 16.8 s (range 4.0 – 
52.0, SD 10.8). One case was abandoned due to difficult 
placement of the LMA. One patient had an episode of 
desaturation to 92% during insertion. No other patient 
desaturated to < 94% at any stage during testing. Median static 
leak and maximal inflation pressures of the laryngeal mask 
component were 32 cmH₂O (range 10.0 to 40.0 cmH₂O) and 40 
cmH₂O (range 16.0 to 40 cmH₂O) respectively. Presence of leak 
was assessed in different head positions: flexion, extension and 
30⁰ left and right of midline. Leak was positive in 12.2% (29/236 
positions in total) with the majority occurring with flexion of the 
head.
The view of the glottis was reported in 59/60 cases, using 
Cormack-Lehane grade and POGO score (Table 3).
Tracheal intubation was successful in 57/60 cases (95%), with a 
first attempt success rate of 86% (51/60) and mean time for 
intubation of 9.5 s (95% CI 14.0 – 19.7, SD 10.8). Two cases were 
abandoned, since tracheal intubation could not be achieved 
within the two allotted attempts. In 25% (15/60) of cases the 
device had to be repositioned (without removal) to obtain an 
adequate laryngeal view.
Total apnoea time was calculated as the sum of LMA insertion 
and tracheal intubation times (mean 25.6 s [95% CI 20.4 – 30.9, 
SD 19.9]). These times were combined to allow for the fact that, 
although ventilation could be continued during tracheal 
intubation, a leak was present due to tracheal tube cuff deflation, 
resulting in a brief reduction in adequate ventilation.
Gastric tube insertion was successful in 91% (52/57) of cases, of 
which 25 had residual gastric content present. Placement was 
regarded as successful if auscultation over the epigastrium 
identified typical sounds during air insufflation via the gastric 
tube.
Supraglottic secretions were present in 79% of cases, and the 
supraglottic suction port was found to be effective in 91%. 
Tracheal tube withdrawal was graded as easy in 92% and 
effective in all cases. The glottic opening was viewed successfully 
in 75% (43/57) of cases post extubation. Failure to view the vocal 
cords was mainly due to excessive secretions which obscured 
the Videotrack® lens. The device was easily removed in all cases 
and there was no soiling of the device in 77% (44/59) of patients.
On the day of procedure, 35% (21/60) reported various grades of 
sore throat, 15% (9/60) reported dysphagia and 8.3% (5/60) 
reported hoarseness.
The 24 h follow-up report showed that 21% (13/60) still 
experienced sore throat, 8.3% (5/60) had dysphagia and 11.6% 
(7/60) were hoarse.
Discussion
The TotalTrack® VLM is a novel airway device, whose components 
allow for supraglottic ventilation, video-assisted laryngoscopy 
and intubation, placement of a nasogastric tube and supraglottic 
suctioning. The testing of the TotalTrack® VLM has shown that 
the device functions well purely as a laryngeal mask, with seal 
pressures comparable to that published in studies of the 
ProSeal™ LMA. The use of the laryngeal mask allows continuous 
ventilation while optimising the view for tracheal intubation. The 
Videotrack® provides a good quality picture with repeated use. 
Intubation success rates are comparable to those published in 
studies of the LMA Fastrach™ and CTrach™. Total apnoea time 
averages less than 30 s. It functions well as a bridging tool at 
induction and emergence.
The TotalTrack® VLM was found to be easy to insert, with only one 
case abandoned because the tip of the laryngeal mask folded 
backwards. Insertion was graded as easy in 77% of patients, and 
the short time taken for insertion reduced total apnoea time. 
Whilst haemodynamic data measured during the insertion and 
tracheal intubation through the device showed statistically 
significant differences, they were not considered to have clinical 
relevance.
On inspection of the laryngeal mask component, the TotalTrack® 
VLM closely resembles the ProSeal™ LMA (which is currently 
considered to be the gold standard second generation 
supraglottic airway), and is consistent in providing high sealing 
pressures. Seal pressures described in the literature regarding 
the ProSeal LMA vary from 22 cmH₂O to 29.5 cmH₂O.12–17 The 
Table 1: Patient characteristics
Mean (SD) Range
Age (yrs) 41 (14) 18 - 73
Height (kg) 71 (14) 42 – 101
Height (cm) 167 (10) 145 – 189
BMI (kg.m–²) 25 (5) 14 – 34
Neck Circumference (cm) 37 (3) 31 – 47
Table 2: Patient demographics and airway characteristics
Number 
Gender Male 23 (38%)
Female 37 (62%)
ASA Class I 24 (40%)
II 36 (60%)




Thyromental Distance < 6 cm 1 (1.6%)
≥ 6 cm 59 (98.3%)
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reported tracheal intubation success rate of between 89.7%23 
and 96%.24–26 A direct comparison of the LMA Fastrach™ and the 
CTrach™ by Liu et al. showed an overall tracheal intubation 
success rate of 96% for the Fastrach and 100% for the CTrach™.26 
In a smaller study in morbidly obese patients, intubation was 
equivalent in the CTrach™ and Fastrach™ at 100% per group.27 
The present study of the TotalTrack® revealed similar success 
rates for tracheal intubation, with a 95% overall success rate, of 
which the majority occurred on first attempt (86%), with a mean 
time of 9 s. View of the glottic opening was good, with a small 
number requiring repositioning of the device for an improved 
view. In two of the abandoned cases, intubation did not occur 
within the two allowed attempts, despite the use of external 
laryngeal manipulation and the use of the supplied endotracheal 
tube introducer.
The time taken to insert the TotalTrack® VLM, as well as intubation 
through the device, was measured. While no ventilation occurred 
during placement of the TotalTrack® VLM, ventilation did 
continue during tracheal intubation, even though a leak was 
present due to tracheal tube cuff deflation. Due to the presence 
of this leak, total apnoea time was calculated from the sum of 
insertion and intubation times. There was a mean total apnoea 
time of 25.6 s. Where Liu et al. compared the Fastrach™ to the 
CTrach™, they found the insertion times of the laryngeal mask 
component alone averaged 23 and 25 s respectively, and tracheal 
intubation times averaged 100 s for the Fastrach™ and 116 s for 
the CTrach™.26 Thus, it can be inferred that the total apnoea time 
for the TotalTrack® VLM was considerably shorter.
Gastric tube insertion and supraglottic suction via the two 
dedicated conduits were effective in more than 90% of cases. It is 
worth noting that while patients in the study were fasted 
preoperatively, 42% (25/52) had residual gastric contents. 
However, these residual volumes were small (2 to 40  ml), and 
although a quarter of devices were soiled with secretions, there 
was only one occurrence of soiling of the laryngeal mask with 
gastric content. This occurred despite the passing of a gastric 
tube, in a patient undergoing laparoscopic surgery. There was no 
evidence of tracheal aspiration.
Incidence of patient-reported side effects diminished on day 1 
post anaesthesia when compared with day 0. Whilst the 
incidence of side effects on follow up is a concern, the frequency 
is similar to that of other devices in various studies.16,28–31 It should 
be noted that, in order to achieve the goals of this study, the 
laryngeal mask portion of the device was left in situ until 
completion of the case. In the normal clinical setting, the 
laryngeal mask portion can be easily removed, leaving only the 
endotracheal tube in situ. Further studies will show whether the 
incidence of side effects is reduced with immediate removal of 
the TotalTrack®VLM once tracheal intubation has been 
completed.
TotalTrack® VLM was shown to have static leak pressures and 
maximal inflation pressures of above 30 cmH₂O, providing 
reliable seal pressures and demonstrating excellent function as a 
supraglottic airway. There was minimal reported leak with 
changes in head positions. No gastric insufflation was found in 
any patient.
The TotalTrack® VLM is a video-assisted intubating laryngeal 
mask, with the Videotrack® display and camera system isolated 
from the patient and therefore reusable. Whilst the current gold 
standard for intubating laryngeal masks is the LMA-Fastrach™, 
the TotalTrack® VLM most resembles the LMA-CTrach™, due to its 
video capabilities. The Fastrach™ has been widely assessed, with 
intubation success rates from 70 to 100%.18–22 The CTrach™ has a 
Figure 3: Mean arterial pressure variation with insertion of  and tracheal 
intubation through the TotalTrack® VLM.
Figure 4: Heart rate variation with insertion of and tracheal intubation 
through the TotalTrack® VLM
Table 3: Grading of glottic view
Grading of glottic view Grade/Score Range Mean (Percentage)
POGO score 100% 52 (88%)
90 – 99% 4 (6.6%)
60 – 89% 1 (1.6%)
< 60% 2 (3.2%)
Cormack & Lehane grade 1 56 (95%)
2 3 (5%)
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A limitation of this study is the sample size, which does not 
guarantee future success rates nor allow for the rigorous 
assessment of safety. Whilst we have provided an initial estimate 
of function, this device requires further study to ascertain the 
appropriate applications. Comparative trials with the current 
gold standards of supraglottic airway devices are warranted for 
evaluation of its utility in the ‘difficult airway’ scenario.
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